Press ESC to close

Peptide Lab App Log in Articles News Guide Products
More Peptide Tracker Calculator Best Calculators Peptide Statistics Contact Newsletter
Français English Deutsch Español العربية Italiano Polski 한국어 日本語 中文 Русский

Are peptides legal in Brazil?

Last verified: Regulator: Agência Nacional de Vigilância Sanitária (Anvisa)

The short answer

In Brazil, a few peptide medicines are legal and registered, mainly the GLP-1 receptor agonists semaglutide and tirzepatide, and since 23 June 2025 pharmacies must retain the prescription when dispensing them. Anvisa states that some injectable peptides hold no registration in any category, so they are illegal for any health use, and that the products presented as GHK-CU, BPC-157, TB500, CJC-1295 and ipamorelin are not registered as medicines; on 6 October 2026 it prohibited the sale of several such unregistered products. Compounded preparations are allowed only one patient at a time, with a medical prescription, and only with substances that have passed efficacy and safety analysis.

Status by category

CategoryStatus
Approved peptide medicinesPrescription only
Research peptidesProhibited
Compounded preparationsRestricted
CosmeticsRestricted
Food supplementsNot authorised
Personal importRestricted
Sport and anti-dopingUnclear

Approved peptide medicines Prescription only

Anvisa describes tirzepatide and semaglutide as medicines that are properly regularised and that passed extensive studies before approval. Since 23 June 2025 pharmacies and drugstores across the country must retain the prescription for GLP-1 agonist medicines such as Ozempic, Mounjaro and Wegovy. Any medicine placed on the national market must prove efficacy, safety and quality through Anvisa registration. [1][3][4]

Research peptides Prohibited

Anvisa states that some injectable peptides are not regularised in any category (food, medicine, cosmetic, food supplement) and are therefore illegal for any health use, including aesthetic use. On 6 October 2026 Anvisa prohibited the sale of several unregistered peptides offered by two websites, and ruled that the products may not be sold, manufactured, distributed, advertised, transported or used, and must be seized. [1][2]

Compounded preparations Restricted

Anvisa states that any substance must have passed efficacy and safety analysis before it can be compounded, and that compounding of any formula may only occur on an individualised basis, with a medical prescription, in compounding pharmacies licensed by the local health authority. On 6 April 2026 Anvisa announced a revision of the compounding rules for injectable GLP-1 medicines, including RDC 67/2007, and reported 11 inspections leading to 8 interdictions in 2026. [1][4]

Cosmetics Restricted

Anvisa states that the injectable products promoted with a supposed aesthetic purpose are not cosmetics, because injectable cosmetics do not exist, and that a product offered in that form is an irregular cosmetic. The source texts say nothing about peptides used in topical cosmetics. [1]

Food supplements Not authorised

Anvisa states that substances such as BPC-157 and TB-500 have no authorisation for use as a food supplement and that no company request or study has been submitted for their regularisation in that category. In addition, no food supplement in Brazil may be given by injection, because the supplement category is limited to oral administration. [1]

Personal import Restricted

For medicines imported by an individual through postal shipment or international air parcel, the federal tax and customs authority states that unregistered medicines may be imported only for personal use, not for resale or trade, and only if they contain no substances subject to special control, and that a medical prescription may be requested as proof of personal or individual use. The same authority states that medicines imported by an individual up to 10,000 dollars are not taxed, that this zero import duty rule is for international parcels and does not apply to other cases such as travellers' baggage, which has its own rules, and that imports of supplements and cosmetics are not included in it and are taxed normally. On its own page about imports by individuals under its administrative control of foreign trade, Anvisa states that the whole process must be done through the single foreign trade portal (Pucomex), by means of the LPCO model intended for imports by individuals, model I00052 - LI / LPCO - Importação por pessoa física. [7][6]

Sport and anti-doping Unclear

No specific official rule found.

Peptide by peptide

PeptideStatusDetails
semaglutidePrescription onlyAnvisa presents semaglutide as an active ingredient of properly regularised medicines, and prescriptions for GLP-1 agonist medicines must be retained by the pharmacy. [1][3][4]
tirzepatidePrescription onlyAnvisa presents tirzepatide as an active ingredient of properly regularised medicines, while unregistered tirzepatide products such as one sold online were prohibited and ordered to be seized on 6 October 2026. [1][2][3]
retatrutideUnclearNo official source gives a status for the substance retatrutide in Brazil; Anvisa prohibited two unregistered retatrutide products sold online on 6 October 2026 and ordered their seizure. [2]
BPC-157ProhibitedBPC-157 is not registered with Anvisa as a medicine and has no authorisation as a food supplement, and a BPC-157 product sold online was prohibited and ordered to be seized. [1][2]
TB-500 (thymosin beta-4)ProhibitedTB-500 is not registered with Anvisa as a medicine and has no authorisation as a food supplement, and a TB-500 product sold online was prohibited and ordered to be seized. [1][2]
GHK-CuProhibitedProducts presented as the peptide GHK-CU are not registered with Anvisa, and a GHK-CU product sold online was prohibited and ordered to be seized. [1][2]
CJC-1295Not authorisedProducts presented as the peptide CJC-1295 are not registered with Anvisa. [1]
ipamorelinNot authorisedProducts presented as the peptide ipamorelin are not registered with Anvisa. [1]

Change history

  1. Prescription retention came into force for GLP-1 agonist medicines such as Ozempic, Mounjaro and Wegovy, giving them stricter control in pharmacies and drugstores. [3]
  2. The 2026 Prohibited List came into force in Brazil, as published by the Brazilian Doping Control Authority. [8]
  3. The semaglutide patent expired in Brazil, but Anvisa restated that registration, with proof of efficacy, safety and quality, remains mandatory before any medicine can be offered on the national market. [4]
  4. Anvisa announced an action plan on injectable GLP-1 medicines: revision of the compounding rules (RDC 67/2007) and of the technical note on importing active ingredients, suspension of licences for at-risk pharmacies, and more inspections of importers. It also reported 10 prohibition actions on irregular GLP-1 products since January 2026. [4]
  5. Anvisa published a fact check stating that some injectable peptides promoted on social media are not regularised in any category and are illegal for any health use, including aesthetic use. [1]
  6. Resolution 3.947/2026 prohibited the sale of several unregistered peptides offered by two websites, listing products containing BPC157 and TB500, GHK-CU, tirzepatide and retatrutide as prohibited and subject to seizure. [2]

Official sources

  1. Checamos: peptídeos que prometem milagres NÃO estão registrados na Anvisa, ANVISA (Agência Nacional de Vigilância Sanitária)
  2. Anvisa proíbe venda de insulina e tirzepatida irregulares (RE nº 3.947/2026), ANVISA
  3. Entra em vigor norma que prevê retenção de receita para medicamentos agonistas GLP-1 (RDC 973/2025, IN 360/2025), ANVISA
  4. Anvisa anuncia novas medidas de combate a irregularidades na importação e manipulação de canetas emagrecedoras, ANVISA
  5. Importação de medicamentos sujeitos a controle especial para uso próprio e fins de tratamento de saúde, ANVISA
  6. Importações por pessoa física, ANVISA
  7. Como importar medicamentos? (remessas postal e expressa), Receita Federal do Brasil (customs)
  8. Substâncias e Métodos Proibidos (Lista Proibida 2026), ABCD - Autoridade Brasileira de Controle de Dopagem

General information, not legal advice. Rules change: check the official source before you act.